Past and Present
More than 100 Issued Patents
Disruptive Platform Technology
More than 100 Issued Patents
$35M Non-dilutive R&D
Disruptive Platform Technology
More than 100 Issued Patents
Disruptive Platform Technology
Disruptive Platform Technology
Disruptive Platform Technology
LEADERSHIP
Bill Gilmour Chief Financial Officer
Gary Strange, Chairman, Emeritus and Sr VP Animal Health
Gary Strange, Chairman, Emeritus and Sr VP Animal Health
Highly experienced with M&A, Fortune 500 companies and extensive financial management
Gary Strange, Chairman, Emeritus and Sr VP Animal Health
Gary Strange, Chairman, Emeritus and Sr VP Animal Health
Gary Strange, Chairman, Emeritus and Sr VP Animal Health
With nearly a decade in Biomed launching LifePulse with commercialization in less than five years.
Bob Roda, President and CEO
Gary Strange, Chairman, Emeritus and Sr VP Animal Health
Christopher Slachta, PhD, MBA COO
Bob brings decades of leadership in both public and private companies with successful exits
Christopher Slachta, PhD, MBA COO
Paula Miliani de Marval, PhD, Sr Director of Research
Christopher Slachta, PhD, MBA COO
Chris has critical expertise with manufacturing, supply chain management and holds a PdD in Molecular Immunology
Paula Miliani de Marval, PhD, Sr Director of Research
Paula Miliani de Marval, PhD, Sr Director of Research
Paula Miliani de Marval, PhD, Sr Director of Research
Paula holds a PhD from MD Anderson and has more than 20 years as a lead researcher in oncology pharmaceuticals
BOARD
C. Richard Piazza, PhD Executive Director
C. Richard Piazza, PhD Executive Director
C. Richard Piazza, PhD Executive Director
Richard brings deep experience as executive chairman in several companies and had many successful exits both public and private
Bob Roda
C. Richard Piazza, PhD Executive Director
C. Richard Piazza, PhD Executive Director
Bob has spent his career in the medical device and pharma industries as CEO of highly successful companies
Gary Strange
C. Richard Piazza, PhD Executive Director
Donald G Fell
Gary founded LifePulse as a veterinary medical device distribution company in 2018 and has a background in executive leadership
Donald G Fell
C. Richard Piazza, PhD Executive Director
Donald G Fell
Don sits on several NASDAQ listed boards and taught the Executive MBA program at several universities including Yale
Gerald Sokol, MD
Gerald Sokol, MD
Gerald Sokol, MD
Dr Sokol is a multi-boarded medical oncologist with deep experience with FDA clinical trials
Gregory Walters
Gerald Sokol, MD
Gerald Sokol, MD
A former SEC attorney, Gregory is a serial entrepreneur with many years' experience in both public and private sector companies
Trinity Bui
Gerald Sokol, MD
Trinity Bui
Trinity is a well-known investor in NYC and is frequently seen ringing the bell at the NASDAQ
About Us
Our History
A combined more than 100 years of collective research produced a series of patents we acquired in 2020 before Pulsed Electrical Fields became one of most important technologies in Biotech.
Our Patents
LifePulse is the beneficiary of more than $35M and decades of R&D that are undiluted investment in the company. This has allowed us to build a fortress of patents surrounding every aspect of our technology.
Our Mission
We are dedicated to make this life changing technology available to the US first, and then the world. The worldwide unmet need is staggering for this disruptive technology. Beginning with pancreatic tumor trials in 2026, we boldly go to change outcomes and quality of life for the terminally ill.
Animal Health Division
LifePulse Bioscience
Since March, 2022 hundreds of dogs, cats and horses have been successfully treated for dozens of indications. Our veterinary devices are now in clinical use throughout the US and soon abroad.
Human Health
LifePulse TM Intellipulse ® technology is a quantum leap forward in targeted therapy. A platform for delivery of therapeutics whose efficacy is improved by cellular delivery, Intellipulse ® brings the first major advancement to Pulsed Electrical Fields in a generation.
Pharmaceutical Division
Innovation in pharmaceuticals is a LifePulse TM prerogative. Watch for new information in the upcoming pipeline. We are developing drugs specifically for delivery with Intellipulse ®. A recently filed PCT patent for a very large protein only deliverable with Intellipulse ® promises to be a watermark discovery.
Join Us
Research Division
Research of therapeutics using cellular delivery is going to change outcomes for millions of patients. Therapeutic delivery at the cellular level in this manner is a game changer in both veterinary and human medicine.
US Engineered and Manufactured Platform Technology
Scientific Excellence
In this interview, our award-winning scientists discuss the future of Pulsed Electrical Fields
Contact Us
Located in the Tampa Bay Medical Park
For clinical trial information contact us at
LifePulse Corporation
